MT-4
MT-4 is a derivative of a tissue transglutaminase (TG2) inhibitor. MT-4 targets the complex of TG2 and fibronectin (FN) (TG2/FN) and inhibits the adhesion of tumor cells to the matrix. MT-4 inhibits the adhesion of ovarian cancer (OC) cells to the peritoneum and increases the sensitivity of OC cells to paclitaxel.
Product Specifications
CAS Number
2327925-35-7
UNSPSC
12352005
Target
Transglutaminase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/mt-4.html
Concentration
10mM
Purity
99.84
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CN(C)C1=NC(NC2=CC=C(NC(CC3=CC=CC=C3)=O)C=C2)=NC(C)=C1
Molecular Formula
C21H23N5O
Molecular Weight
361.44
References & Citations
[1]Sima LE, et al. Small Molecules Target the Interaction between Tissue Transglutaminase and Fibronectin. Mol Cancer Ther. 2019 Jun;18 (6) :1057-1068.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC143117-100 1x 100 µL
CD19 (B-Lymphocyte Marker) (CD19/3117), CF514 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
E-CL-H0452-01 24 Tests
Human BALP (Bone Alkaline Phosphatase) CLIA Kit
Sign In for Pricing
View Details E-CL-H0452-02 48 Tests
Human BALP (Bone Alkaline Phosphatase) CLIA Kit
Sign In for Pricing
View Details E-CL-H0452-03 96 Tests
Human BALP (Bone Alkaline Phosphatase) CLIA Kit
Sign In for Pricing
View Details 